| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome-Wide Association Study | 132 | 2024 | 12261 | 4.580 |
Why?
|
| Bipolar Disorder | 69 | 2024 | 5027 | 4.250 |
Why?
|
| Multifactorial Inheritance | 40 | 2023 | 1194 | 3.520 |
Why?
|
| Depressive Disorder, Major | 57 | 2024 | 4644 | 3.430 |
Why?
|
| Schizophrenia | 54 | 2023 | 6882 | 3.110 |
Why?
|
| Genetic Predisposition to Disease | 129 | 2024 | 17446 | 3.110 |
Why?
|
| Mental Disorders | 37 | 2023 | 6600 | 2.840 |
Why?
|
| Anxiety Disorders | 29 | 2023 | 2690 | 2.780 |
Why?
|
| Suicide, Attempted | 22 | 2024 | 1221 | 2.740 |
Why?
|
| Panic Disorder | 18 | 2015 | 616 | 2.650 |
Why?
|
| Polymorphism, Single Nucleotide | 115 | 2023 | 15519 | 2.450 |
Why?
|
| Depression | 34 | 2023 | 7766 | 2.140 |
Why?
|
| Electronic Health Records | 28 | 2024 | 4468 | 1.760 |
Why?
|
| Phenotype | 69 | 2023 | 16365 | 1.740 |
Why?
|
| Genomics | 23 | 2023 | 5720 | 1.670 |
Why?
|
| Psychiatry | 12 | 2018 | 1695 | 1.540 |
Why?
|
| Quantitative Trait, Heritable | 10 | 2020 | 544 | 1.460 |
Why?
|
| Stress Disorders, Post-Traumatic | 25 | 2023 | 4266 | 1.270 |
Why?
|
| Military Personnel | 12 | 2024 | 1133 | 1.260 |
Why?
|
| Psychopathology | 2 | 2022 | 409 | 1.180 |
Why?
|
| Depressive Disorder | 14 | 2021 | 3748 | 1.180 |
Why?
|
| Humans | 398 | 2024 | 744343 | 1.100 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 23 | 2023 | 3658 | 1.070 |
Why?
|
| Alcoholism | 7 | 2023 | 1906 | 1.060 |
Why?
|
| Anxiety | 23 | 2023 | 4297 | 1.030 |
Why?
|
| Suicidal Ideation | 11 | 2024 | 1248 | 1.030 |
Why?
|
| Genetic Variation | 25 | 2022 | 6544 | 1.000 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 11 | 2018 | 1953 | 0.990 |
Why?
|
| Cation Transport Proteins | 4 | 2023 | 327 | 0.980 |
Why?
|
| Resilience, Psychological | 6 | 2019 | 676 | 0.980 |
Why?
|
| Bereavement | 3 | 2013 | 277 | 0.970 |
Why?
|
| Antidepressive Agents | 17 | 2022 | 2838 | 0.950 |
Why?
|
| Genotype | 55 | 2022 | 12951 | 0.920 |
Why?
|
| Brain | 38 | 2023 | 26385 | 0.920 |
Why?
|
| Personality | 6 | 2017 | 552 | 0.900 |
Why?
|
| RGS Proteins | 3 | 2013 | 77 | 0.880 |
Why?
|
| Genetic Loci | 19 | 2023 | 2575 | 0.850 |
Why?
|
| Female | 222 | 2023 | 380194 | 0.840 |
Why?
|
| Pharmacogenetics | 7 | 2014 | 675 | 0.810 |
Why?
|
| Genetic Diseases, Inborn | 3 | 2017 | 587 | 0.810 |
Why?
|
| Child Abuse | 6 | 2020 | 1030 | 0.800 |
Why?
|
| Calcium Channels, L-Type | 7 | 2017 | 240 | 0.790 |
Why?
|
| Cognition | 13 | 2023 | 6770 | 0.790 |
Why?
|
| Cerebral Cortex | 13 | 2023 | 5708 | 0.780 |
Why?
|
| Male | 197 | 2023 | 350118 | 0.780 |
Why?
|
| Linkage Disequilibrium | 19 | 2021 | 1997 | 0.780 |
Why?
|
| Risk Factors | 77 | 2024 | 72290 | 0.770 |
Why?
|
| Suicide | 5 | 2023 | 1477 | 0.750 |
Why?
|
| Adult | 148 | 2024 | 214055 | 0.720 |
Why?
|
| Phobic Disorders | 4 | 2008 | 439 | 0.700 |
Why?
|
| Aptitude | 1 | 2019 | 45 | 0.690 |
Why?
|
| Human Development | 4 | 2021 | 124 | 0.690 |
Why?
|
| Manganese | 3 | 2022 | 408 | 0.690 |
Why?
|
| Facial Expression | 4 | 2019 | 508 | 0.670 |
Why?
|
| Glutamic Acid | 4 | 2015 | 1169 | 0.660 |
Why?
|
| Risk Assessment | 17 | 2024 | 23338 | 0.640 |
Why?
|
| Psychotic Disorders | 13 | 2023 | 3046 | 0.630 |
Why?
|
| Mental Health | 9 | 2022 | 3019 | 0.620 |
Why?
|
| Intelligence | 4 | 2020 | 920 | 0.610 |
Why?
|
| Genome, Human | 9 | 2021 | 4420 | 0.610 |
Why?
|
| Emotional Intelligence | 2 | 2016 | 136 | 0.600 |
Why?
|
| Case-Control Studies | 47 | 2024 | 21746 | 0.600 |
Why?
|
| Genetics | 1 | 2017 | 112 | 0.580 |
Why?
|
| Anger | 6 | 2019 | 402 | 0.570 |
Why?
|
| Amygdala | 5 | 2021 | 1315 | 0.570 |
Why?
|
| Genetic Pleiotropy | 5 | 2022 | 182 | 0.570 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 3 | 2008 | 514 | 0.560 |
Why?
|
| Social Environment | 5 | 2014 | 1023 | 0.550 |
Why?
|
| Adolescent | 66 | 2024 | 85781 | 0.550 |
Why?
|
| Folic Acid | 5 | 2017 | 1300 | 0.550 |
Why?
|
| Models, Genetic | 10 | 2019 | 3494 | 0.550 |
Why?
|
| Aftercare | 2 | 2023 | 866 | 0.540 |
Why?
|
| Middle Aged | 104 | 2023 | 213383 | 0.540 |
Why?
|
| Young Adult | 60 | 2023 | 56430 | 0.540 |
Why?
|
| Corticotropin-Releasing Hormone | 3 | 2005 | 369 | 0.530 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 9 | 2013 | 322 | 0.530 |
Why?
|
| Gene Frequency | 18 | 2021 | 3588 | 0.510 |
Why?
|
| Mood Disorders | 4 | 2022 | 1106 | 0.500 |
Why?
|
| Child | 64 | 2024 | 77709 | 0.490 |
Why?
|
| Biological Specimen Banks | 7 | 2021 | 711 | 0.490 |
Why?
|
| Sertraline | 3 | 2013 | 206 | 0.490 |
Why?
|
| Vitamin B 12 | 2 | 2014 | 527 | 0.490 |
Why?
|
| Affect | 3 | 2022 | 1476 | 0.490 |
Why?
|
| Williams Syndrome | 1 | 2016 | 187 | 0.480 |
Why?
|
| Longitudinal Studies | 25 | 2023 | 13989 | 0.470 |
Why?
|
| Theory of Mind | 1 | 2015 | 86 | 0.470 |
Why?
|
| Educational Status | 4 | 2022 | 2540 | 0.460 |
Why?
|
| Genetic Linkage | 12 | 2011 | 2421 | 0.460 |
Why?
|
| Inheritance Patterns | 2 | 2015 | 340 | 0.460 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 7 | 2014 | 422 | 0.450 |
Why?
|
| Vitamin B 6 | 1 | 2014 | 237 | 0.450 |
Why?
|
| Chromosomes, Human, Pair 6 | 4 | 2018 | 380 | 0.440 |
Why?
|
| Data Mining | 2 | 2018 | 537 | 0.440 |
Why?
|
| Temperament | 4 | 2009 | 283 | 0.440 |
Why?
|
| Genetic Testing | 7 | 2022 | 3444 | 0.440 |
Why?
|
| Emotions | 7 | 2022 | 2661 | 0.430 |
Why?
|
| Models, Statistical | 7 | 2021 | 5102 | 0.430 |
Why?
|
| Catechol O-Methyltransferase | 5 | 2016 | 245 | 0.420 |
Why?
|
| Cohort Studies | 34 | 2022 | 40561 | 0.420 |
Why?
|
| Glutamine | 2 | 2015 | 578 | 0.410 |
Why?
|
| Electrophysiology | 1 | 2015 | 1308 | 0.410 |
Why?
|
| Cyclonic Storms | 1 | 2013 | 119 | 0.410 |
Why?
|
| Genetic Markers | 15 | 2016 | 2634 | 0.400 |
Why?
|
| Citalopram | 4 | 2014 | 403 | 0.390 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2013 | 315 | 0.390 |
Why?
|
| Exercise | 4 | 2020 | 5615 | 0.390 |
Why?
|
| DNA Copy Number Variations | 5 | 2018 | 1941 | 0.390 |
Why?
|
| Glutaminase | 1 | 2011 | 35 | 0.390 |
Why?
|
| Chromosome Mapping | 14 | 2013 | 4740 | 0.390 |
Why?
|
| Postmenopause | 5 | 2013 | 2461 | 0.380 |
Why?
|
| Alleles | 21 | 2022 | 6933 | 0.380 |
Why?
|
| Twin Studies as Topic | 5 | 2015 | 105 | 0.380 |
Why?
|
| Polymorphism, Genetic | 10 | 2015 | 4328 | 0.380 |
Why?
|
| Stress, Psychological | 5 | 2020 | 4245 | 0.370 |
Why?
|
| Receptor, Serotonin, 5-HT1B | 3 | 2007 | 33 | 0.370 |
Why?
|
| Cost-Benefit Analysis | 3 | 2021 | 5391 | 0.360 |
Why?
|
| Vitamin D Deficiency | 1 | 2020 | 1343 | 0.360 |
Why?
|
| Child Development | 4 | 2015 | 2223 | 0.360 |
Why?
|
| Minors | 1 | 2010 | 50 | 0.360 |
Why?
|
| Psychotropic Drugs | 4 | 2017 | 894 | 0.360 |
Why?
|
| Child Development Disorders, Pervasive | 3 | 2014 | 615 | 0.350 |
Why?
|
| Tourette Syndrome | 4 | 2021 | 379 | 0.350 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2010 | 417 | 0.340 |
Why?
|
| Bayes Theorem | 7 | 2023 | 2309 | 0.340 |
Why?
|
| Genetic Association Studies | 8 | 2021 | 2703 | 0.330 |
Why?
|
| Veterans | 4 | 2023 | 2519 | 0.330 |
Why?
|
| Drug Repositioning | 2 | 2023 | 229 | 0.330 |
Why?
|
| Magnetic Resonance Imaging | 31 | 2021 | 35421 | 0.330 |
Why?
|
| Lithium Compounds | 4 | 2016 | 225 | 0.330 |
Why?
|
| Aged | 52 | 2021 | 163280 | 0.330 |
Why?
|
| Natural Language Processing | 5 | 2018 | 1041 | 0.320 |
Why?
|
| Organ Size | 8 | 2023 | 2252 | 0.320 |
Why?
|
| Prospective Studies | 23 | 2023 | 53288 | 0.320 |
Why?
|
| Primary Health Care | 2 | 2022 | 4558 | 0.320 |
Why?
|
| Genetics, Medical | 2 | 2015 | 338 | 0.310 |
Why?
|
| 1-Naphthylamine | 2 | 1998 | 49 | 0.310 |
Why?
|
| Comorbidity | 18 | 2023 | 10388 | 0.310 |
Why?
|
| Sex Characteristics | 6 | 2021 | 2585 | 0.310 |
Why?
|
| Harm Reduction | 1 | 2009 | 129 | 0.310 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2008 | 58 | 0.310 |
Why?
|
| Self Report | 7 | 2022 | 3558 | 0.300 |
Why?
|
| Glycosylation | 5 | 2022 | 1126 | 0.300 |
Why?
|
| Disasters | 1 | 2013 | 511 | 0.300 |
Why?
|
| Life Change Events | 5 | 2022 | 938 | 0.300 |
Why?
|
| Risk | 9 | 2023 | 9687 | 0.290 |
Why?
|
| United States | 30 | 2024 | 69872 | 0.290 |
Why?
|
| Psychiatric Status Rating Scales | 16 | 2017 | 6038 | 0.280 |
Why?
|
| Synaptic Transmission | 1 | 2012 | 1178 | 0.280 |
Why?
|
| Polysaccharides | 3 | 2023 | 1053 | 0.280 |
Why?
|
| Self-Injurious Behavior | 2 | 2024 | 465 | 0.280 |
Why?
|
| Obstetric Labor Complications | 2 | 2019 | 238 | 0.270 |
Why?
|
| Somatoform Disorders | 1 | 2009 | 423 | 0.270 |
Why?
|
| Disease | 2 | 2021 | 680 | 0.260 |
Why?
|
| Genetic Research | 3 | 2021 | 174 | 0.260 |
Why?
|
| Delivery of Health Care | 3 | 2020 | 5319 | 0.260 |
Why?
|
| Cardiovascular Diseases | 8 | 2023 | 15165 | 0.260 |
Why?
|
| Brain-Derived Neurotrophic Factor | 4 | 2013 | 604 | 0.260 |
Why?
|
| Hippocampus | 7 | 2021 | 3675 | 0.260 |
Why?
|
| Dementia | 3 | 2014 | 2518 | 0.260 |
Why?
|
| Emergency Service, Hospital | 3 | 2023 | 7659 | 0.260 |
Why?
|
| Biomedical Research | 3 | 2021 | 3309 | 0.260 |
Why?
|
| Age of Onset | 8 | 2021 | 3271 | 0.250 |
Why?
|
| Brain Chemistry | 2 | 2008 | 981 | 0.250 |
Why?
|
| Meta-Analysis as Topic | 7 | 2020 | 1344 | 0.250 |
Why?
|
| Obsessive-Compulsive Disorder | 7 | 2021 | 1444 | 0.250 |
Why?
|
| Environment | 3 | 2020 | 1124 | 0.250 |
Why?
|
| Affective Disorders, Psychotic | 2 | 2017 | 191 | 0.250 |
Why?
|
| Chromosomes, Human, Pair 12 | 4 | 2012 | 462 | 0.250 |
Why?
|
| Nervous System Diseases | 3 | 2022 | 1622 | 0.240 |
Why?
|
| Haplotypes | 8 | 2019 | 2779 | 0.240 |
Why?
|
| Nerve Net | 5 | 2016 | 2174 | 0.240 |
Why?
|
| Dissociative Disorders | 2 | 2022 | 231 | 0.240 |
Why?
|
| Dyspnea | 4 | 2006 | 1303 | 0.240 |
Why?
|
| Databases, Genetic | 4 | 2019 | 1783 | 0.240 |
Why?
|
| Cross-Sectional Studies | 16 | 2022 | 25043 | 0.240 |
Why?
|
| Antidepressive Agents, Second-Generation | 4 | 2014 | 503 | 0.240 |
Why?
|
| Calcium-Binding Proteins | 1 | 2009 | 1081 | 0.230 |
Why?
|
| ROC Curve | 4 | 2023 | 3527 | 0.230 |
Why?
|
| Personality Inventory | 5 | 2011 | 1030 | 0.230 |
Why?
|
| Rats, Zucker | 3 | 1995 | 128 | 0.230 |
Why?
|
| Parents | 6 | 2024 | 3407 | 0.230 |
Why?
|
| National Institute of Mental Health (U.S.) | 2 | 2016 | 107 | 0.230 |
Why?
|
| Nerve Tissue Proteins | 9 | 2017 | 4462 | 0.230 |
Why?
|
| Mendelian Randomization Analysis | 4 | 2023 | 967 | 0.230 |
Why?
|
| Penetrance | 3 | 2019 | 381 | 0.220 |
Why?
|
| Multicenter Studies as Topic | 2 | 2020 | 1677 | 0.220 |
Why?
|
| Logistic Models | 12 | 2021 | 13408 | 0.220 |
Why?
|
| Sex Factors | 10 | 2020 | 10397 | 0.220 |
Why?
|
| Brain Diseases | 3 | 2018 | 1563 | 0.220 |
Why?
|
| Marital Status | 2 | 2022 | 437 | 0.220 |
Why?
|
| Selection Bias | 2 | 2023 | 371 | 0.220 |
Why?
|
| Heredity | 1 | 2023 | 154 | 0.220 |
Why?
|
| Divorce | 1 | 2022 | 79 | 0.220 |
Why?
|
| Alzheimer Disease | 9 | 2018 | 8037 | 0.220 |
Why?
|
| Bupropion | 2 | 2022 | 303 | 0.210 |
Why?
|
| Molecular Biology | 5 | 2023 | 596 | 0.210 |
Why?
|
| Nepal | 1 | 2023 | 295 | 0.210 |
Why?
|
| Genetic Counseling | 1 | 2006 | 600 | 0.210 |
Why?
|
| Stroke | 2 | 2018 | 9981 | 0.210 |
Why?
|
| Health Surveys | 7 | 2020 | 4037 | 0.210 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 2 | 2013 | 87 | 0.210 |
Why?
|
| Drug Resistance | 1 | 2008 | 1609 | 0.200 |
Why?
|
| Fear | 2 | 2019 | 1440 | 0.200 |
Why?
|
| Algorithms | 10 | 2021 | 13881 | 0.200 |
Why?
|
| Receptors, Dopamine D4 | 4 | 2014 | 171 | 0.200 |
Why?
|
| Multivariate Analysis | 8 | 2019 | 12245 | 0.200 |
Why?
|
| Genome | 4 | 2023 | 1808 | 0.200 |
Why?
|
| Mutation, Missense | 5 | 2020 | 2564 | 0.200 |
Why?
|
| Socioeconomic Factors | 7 | 2020 | 7785 | 0.200 |
Why?
|
| History, 21st Century | 2 | 2018 | 1534 | 0.200 |
Why?
|
| Reward | 3 | 2016 | 941 | 0.200 |
Why?
|
| Pregnancy Complications | 4 | 2019 | 2861 | 0.200 |
Why?
|
| Brain Mapping | 8 | 2020 | 6669 | 0.200 |
Why?
|
| Carrier Proteins | 5 | 2020 | 5021 | 0.190 |
Why?
|
| Norepinephrine Plasma Membrane Transport Proteins | 2 | 2013 | 66 | 0.190 |
Why?
|
| Family Health | 5 | 2009 | 1282 | 0.190 |
Why?
|
| History, 20th Century | 3 | 2018 | 2740 | 0.190 |
Why?
|
| Evoked Potentials, Auditory | 2 | 2015 | 525 | 0.190 |
Why?
|
| Congenital Disorders of Glycosylation | 1 | 2020 | 45 | 0.190 |
Why?
|
| Reproducibility of Results | 11 | 2023 | 19905 | 0.190 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 2020 | 72 | 0.180 |
Why?
|
| Genetic Techniques | 2 | 2017 | 435 | 0.180 |
Why?
|
| Glutamate Decarboxylase | 1 | 2001 | 245 | 0.180 |
Why?
|
| Protoporphyria, Erythropoietic | 1 | 2020 | 43 | 0.180 |
Why?
|
| New England | 5 | 2017 | 1022 | 0.180 |
Why?
|
| Neuropsychological Tests | 8 | 2020 | 6993 | 0.180 |
Why?
|
| Antimanic Agents | 3 | 2015 | 522 | 0.180 |
Why?
|
| DNA | 5 | 2021 | 7301 | 0.180 |
Why?
|
| International Classification of Diseases | 2 | 2018 | 867 | 0.180 |
Why?
|
| Lung Diseases, Obstructive | 2 | 1998 | 316 | 0.180 |
Why?
|
| Avoidance Learning | 3 | 2010 | 233 | 0.180 |
Why?
|
| Placebo Effect | 2 | 2014 | 502 | 0.180 |
Why?
|
| Prefrontal Cortex | 3 | 2020 | 2147 | 0.180 |
Why?
|
| Tobacco Use Disorder | 3 | 2016 | 688 | 0.180 |
Why?
|
| Marijuana Abuse | 1 | 2023 | 403 | 0.170 |
Why?
|
| Endophenotypes | 3 | 2017 | 250 | 0.170 |
Why?
|
| Data Interpretation, Statistical | 5 | 2020 | 2716 | 0.170 |
Why?
|
| Multiple Trauma | 1 | 2022 | 367 | 0.170 |
Why?
|
| Fluoxetine | 2 | 2003 | 749 | 0.170 |
Why?
|
| Stress Disorders, Traumatic | 1 | 2019 | 53 | 0.170 |
Why?
|
| Chest Pain | 1 | 2006 | 1114 | 0.170 |
Why?
|
| Women's Health | 4 | 2017 | 2034 | 0.170 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2022 | 11725 | 0.170 |
Why?
|
| Receptors, Dopamine D5 | 3 | 2007 | 32 | 0.170 |
Why?
|
| Synaptosomal-Associated Protein 25 | 3 | 2007 | 52 | 0.170 |
Why?
|
| Tacrolimus Binding Proteins | 2 | 2013 | 195 | 0.170 |
Why?
|
| Adaptation, Psychological | 3 | 2019 | 2576 | 0.170 |
Why?
|
| Sensitivity and Specificity | 6 | 2021 | 14722 | 0.170 |
Why?
|
| Child, Preschool | 17 | 2022 | 41006 | 0.170 |
Why?
|
| Glycomics | 1 | 2020 | 121 | 0.170 |
Why?
|
| Substance-Related Disorders | 6 | 2024 | 4258 | 0.170 |
Why?
|
| Depression, Postpartum | 1 | 2023 | 340 | 0.170 |
Why?
|
| Happiness | 2 | 2019 | 170 | 0.160 |
Why?
|
| Schizophrenic Psychology | 3 | 2016 | 1678 | 0.160 |
Why?
|
| Frontal Lobe | 3 | 2015 | 1406 | 0.160 |
Why?
|
| Tic Disorders | 1 | 2019 | 127 | 0.160 |
Why?
|
| Databases as Topic | 1 | 2020 | 475 | 0.160 |
Why?
|
| Wills | 1 | 2017 | 14 | 0.160 |
Why?
|
| Menstrual Cycle | 2 | 2018 | 551 | 0.160 |
Why?
|
| Gyrus Cinguli | 5 | 2016 | 1091 | 0.160 |
Why?
|
| Impulsive Behavior | 2 | 2021 | 316 | 0.160 |
Why?
|
| Twins | 2 | 2016 | 339 | 0.160 |
Why?
|
| Event-Related Potentials, P300 | 2 | 2015 | 150 | 0.160 |
Why?
|
| Beauty | 2 | 2015 | 42 | 0.160 |
Why?
|
| Chromosome Aberrations | 3 | 2021 | 1813 | 0.160 |
Why?
|
| Quantitative Trait Loci | 5 | 2021 | 2019 | 0.160 |
Why?
|
| Follow-Up Studies | 12 | 2017 | 39050 | 0.150 |
Why?
|
| Afghan Campaign 2001- | 1 | 2019 | 272 | 0.150 |
Why?
|
| Basal Ganglia | 1 | 2020 | 546 | 0.150 |
Why?
|
| Pain | 3 | 2022 | 4986 | 0.150 |
Why?
|
| Databases, Factual | 6 | 2021 | 7729 | 0.150 |
Why?
|
| History, 19th Century | 2 | 2018 | 720 | 0.150 |
Why?
|
| Social Class | 2 | 2017 | 1999 | 0.150 |
Why?
|
| Pregnancy | 9 | 2023 | 29144 | 0.150 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2018 | 271 | 0.150 |
Why?
|
| Chromosomes, Human | 2 | 2021 | 457 | 0.150 |
Why?
|
| Minority Groups | 2 | 2023 | 1223 | 0.150 |
Why?
|
| Tetrahydrofolates | 1 | 2017 | 61 | 0.140 |
Why?
|
| Premenstrual Syndrome | 1 | 1997 | 109 | 0.140 |
Why?
|
| Corpus Striatum | 2 | 2021 | 1221 | 0.140 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 3 | 2014 | 284 | 0.140 |
Why?
|
| Biomarkers, Pharmacological | 2 | 2015 | 162 | 0.140 |
Why?
|
| Transcription Factors | 2 | 2013 | 12208 | 0.140 |
Why?
|
| Odds Ratio | 5 | 2021 | 9849 | 0.140 |
Why?
|
| Pedigree | 5 | 2019 | 4644 | 0.140 |
Why?
|
| Neuroanatomy | 1 | 2016 | 66 | 0.140 |
Why?
|
| Incidence | 6 | 2017 | 20947 | 0.140 |
Why?
|
| Kynurenic Acid | 1 | 2015 | 46 | 0.140 |
Why?
|
| Glycoproteins | 2 | 2022 | 2263 | 0.140 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 3 | 2018 | 1114 | 0.140 |
Why?
|
| Family | 8 | 2014 | 3147 | 0.130 |
Why?
|
| Myocardial Ischemia | 1 | 2006 | 2148 | 0.130 |
Why?
|
| Obesity | 8 | 2021 | 12745 | 0.130 |
Why?
|
| Huntington Disease | 2 | 2015 | 1124 | 0.130 |
Why?
|
| Schools | 2 | 2022 | 1433 | 0.130 |
Why?
|
| Prevalence | 11 | 2021 | 15226 | 0.130 |
Why?
|
| Interview, Psychological | 1 | 2019 | 812 | 0.130 |
Why?
|
| Autistic Disorder | 2 | 2023 | 1185 | 0.130 |
Why?
|
| Lithium | 2 | 2015 | 601 | 0.130 |
Why?
|
| Psychology | 1 | 2017 | 356 | 0.130 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2021 | 738 | 0.130 |
Why?
|
| Adolescent Behavior | 1 | 2024 | 1151 | 0.130 |
Why?
|
| Pandemics | 4 | 2022 | 8388 | 0.130 |
Why?
|
| Individuality | 2 | 2016 | 307 | 0.130 |
Why?
|
| Erectile Dysfunction | 1 | 2018 | 461 | 0.130 |
Why?
|
| Thalamus | 1 | 2021 | 1023 | 0.120 |
Why?
|
| Computer Simulation | 6 | 2019 | 6196 | 0.120 |
Why?
|
| Linear Models | 8 | 2019 | 5952 | 0.120 |
Why?
|
| Exploratory Behavior | 1 | 2016 | 270 | 0.120 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2014 | 45 | 0.120 |
Why?
|
| Physician-Patient Relations | 2 | 2022 | 3229 | 0.120 |
Why?
|
| Appointments and Schedules | 1 | 1998 | 417 | 0.120 |
Why?
|
| Models, Animal | 1 | 2001 | 2171 | 0.120 |
Why?
|
| Vesicular Monoamine Transport Proteins | 1 | 2014 | 32 | 0.120 |
Why?
|
| Microvessels | 1 | 2018 | 544 | 0.120 |
Why?
|
| New Orleans | 1 | 2013 | 27 | 0.120 |
Why?
|
| Esthetics | 1 | 2015 | 306 | 0.120 |
Why?
|
| Cognition Disorders | 4 | 2017 | 4043 | 0.120 |
Why?
|
| Trinucleotide Repeats | 1 | 2015 | 261 | 0.120 |
Why?
|
| Intelligence Tests | 1 | 2015 | 505 | 0.120 |
Why?
|
| Apolipoprotein E4 | 1 | 2018 | 668 | 0.120 |
Why?
|
| Child Behavior Disorders | 2 | 2017 | 807 | 0.120 |
Why?
|
| Reproduction | 1 | 2018 | 668 | 0.120 |
Why?
|
| Ankyrins | 2 | 2017 | 128 | 0.120 |
Why?
|
| Post-Concussion Syndrome | 1 | 2016 | 219 | 0.120 |
Why?
|
| Residence Characteristics | 1 | 2023 | 2050 | 0.110 |
Why?
|
| Aged, 80 and over | 12 | 2021 | 57776 | 0.110 |
Why?
|
| Functional Laterality | 1 | 2020 | 2290 | 0.110 |
Why?
|
| Achievement | 1 | 2015 | 291 | 0.110 |
Why?
|
| Motor Activity | 3 | 2015 | 2714 | 0.110 |
Why?
|
| Receptors, Oxytocin | 1 | 2013 | 66 | 0.110 |
Why?
|
| Receptors, Dopamine | 1 | 2014 | 295 | 0.110 |
Why?
|
| Publication Bias | 1 | 2014 | 162 | 0.110 |
Why?
|
| Attitude of Health Personnel | 2 | 2005 | 3843 | 0.110 |
Why?
|
| Likelihood Functions | 3 | 2011 | 1005 | 0.110 |
Why?
|
| Diet, Reducing | 2 | 1987 | 462 | 0.110 |
Why?
|
| Pattern Recognition, Visual | 2 | 2010 | 824 | 0.110 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2015 | 257 | 0.110 |
Why?
|
| Hypothalamus | 1 | 2018 | 1063 | 0.110 |
Why?
|
| Amyloid | 1 | 2018 | 795 | 0.110 |
Why?
|
| Metabolomics | 1 | 2021 | 1484 | 0.110 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2015 | 3760 | 0.110 |
Why?
|
| Registries | 4 | 2018 | 8089 | 0.110 |
Why?
|
| Mental Recall | 1 | 2019 | 1205 | 0.110 |
Why?
|
| Communicable Diseases | 1 | 2021 | 880 | 0.110 |
Why?
|
| Evoked Potentials | 2 | 2018 | 1056 | 0.110 |
Why?
|
| Pain Perception | 1 | 2014 | 191 | 0.110 |
Why?
|
| Neurologic Examination | 1 | 2015 | 930 | 0.110 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2014 | 434 | 0.110 |
Why?
|
| Chronic Disease | 3 | 2024 | 9146 | 0.100 |
Why?
|
| Climacteric | 1 | 2012 | 57 | 0.100 |
Why?
|
| Research Design | 5 | 2019 | 5987 | 0.100 |
Why?
|
| Adult Survivors of Child Abuse | 1 | 2015 | 260 | 0.100 |
Why?
|
| Social Support | 1 | 2022 | 2118 | 0.100 |
Why?
|
| Animals | 18 | 2023 | 168757 | 0.100 |
Why?
|
| Mutation | 4 | 2022 | 29786 | 0.100 |
Why?
|
| Diseases in Twins | 2 | 2008 | 449 | 0.100 |
Why?
|
| ADAM Proteins | 1 | 2013 | 243 | 0.100 |
Why?
|
| alpha Catenin | 1 | 2011 | 38 | 0.100 |
Why?
|
| Research | 2 | 2014 | 1999 | 0.100 |
Why?
|
| Treatment Outcome | 12 | 2017 | 63114 | 0.100 |
Why?
|
| Motor Cortex | 1 | 2019 | 986 | 0.100 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2018 | 1205 | 0.100 |
Why?
|
| Psychotherapy | 2 | 1998 | 1643 | 0.100 |
Why?
|
| Coronary Artery Disease | 3 | 2021 | 6487 | 0.100 |
Why?
|
| Temporal Lobe | 1 | 2019 | 1670 | 0.100 |
Why?
|
| Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I | 1 | 2011 | 52 | 0.100 |
Why?
|
| Antipsychotic Agents | 4 | 2017 | 3057 | 0.100 |
Why?
|
| Research Support as Topic | 1 | 2016 | 705 | 0.100 |
Why?
|
| Receptors, Nicotinic | 2 | 2012 | 497 | 0.100 |
Why?
|
| Asthma | 2 | 2022 | 6011 | 0.100 |
Why?
|
| Infant | 8 | 2021 | 35136 | 0.100 |
Why?
|
| Psychomotor Agitation | 2 | 2011 | 293 | 0.100 |
Why?
|
| Infant, Newborn | 5 | 2023 | 25625 | 0.100 |
Why?
|
| Migraine Disorders | 1 | 2003 | 1620 | 0.100 |
Why?
|
| Executive Function | 2 | 2020 | 1364 | 0.100 |
Why?
|
| Pregnancy Outcome | 2 | 2019 | 2795 | 0.100 |
Why?
|
| Obesity, Morbid | 1 | 2021 | 1213 | 0.100 |
Why?
|
| Remission Induction | 2 | 2013 | 2386 | 0.100 |
Why?
|
| Diet | 2 | 2020 | 7939 | 0.090 |
Why?
|
| Philosophy, Medical | 1 | 1991 | 79 | 0.090 |
Why?
|
| Respiratory Tract Diseases | 1 | 1996 | 722 | 0.090 |
Why?
|
| Students | 2 | 2024 | 1654 | 0.090 |
Why?
|
| Receptor, Serotonin, 5-HT2A | 1 | 2010 | 63 | 0.090 |
Why?
|
| Receptor, Serotonin, 5-HT1A | 1 | 2010 | 53 | 0.090 |
Why?
|
| Body Mass Index | 4 | 2021 | 12720 | 0.090 |
Why?
|
| Receptors, AMPA | 2 | 2009 | 331 | 0.090 |
Why?
|
| Adrenomedullin | 1 | 2010 | 87 | 0.090 |
Why?
|
| Drosophila melanogaster | 1 | 2019 | 1708 | 0.090 |
Why?
|
| Child Behavior | 2 | 2010 | 839 | 0.090 |
Why?
|
| Personality Assessment | 2 | 2010 | 647 | 0.090 |
Why?
|
| Wit and Humor as Topic | 1 | 2010 | 31 | 0.090 |
Why?
|
| Smoking | 3 | 2012 | 8987 | 0.090 |
Why?
|
| Aging | 5 | 2021 | 8664 | 0.090 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 2 | 2018 | 1004 | 0.090 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2019 | 1861 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2011 | 326 | 0.090 |
Why?
|
| Circadian Rhythm Signaling Peptides and Proteins | 1 | 2009 | 30 | 0.090 |
Why?
|
| Professional Practice | 2 | 2005 | 326 | 0.090 |
Why?
|
| Motor Vehicles | 2 | 2022 | 268 | 0.090 |
Why?
|
| Alcohol Drinking | 1 | 2022 | 3966 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 1 | 3 | 2015 | 658 | 0.090 |
Why?
|
| Proportional Hazards Models | 3 | 2014 | 12354 | 0.090 |
Why?
|
| Prognosis | 4 | 2020 | 29063 | 0.090 |
Why?
|
| Breast Neoplasms | 3 | 2023 | 20822 | 0.090 |
Why?
|
| Ventral Tegmental Area | 1 | 2010 | 142 | 0.090 |
Why?
|
| Clinical Competence | 1 | 2005 | 4687 | 0.090 |
Why?
|
| Limbic System | 1 | 2012 | 426 | 0.090 |
Why?
|
| Face | 1 | 2015 | 994 | 0.090 |
Why?
|
| Renal Insufficiency | 1 | 2015 | 804 | 0.090 |
Why?
|
| Disease Management | 1 | 2020 | 2459 | 0.090 |
Why?
|
| Pneumonia | 1 | 2021 | 2133 | 0.090 |
Why?
|
| Brain Waves | 1 | 2013 | 401 | 0.090 |
Why?
|
| Adolescent Development | 1 | 2012 | 278 | 0.080 |
Why?
|
| Neutrophils | 1 | 2021 | 3719 | 0.080 |
Why?
|
| Acupuncture Therapy | 1 | 2013 | 464 | 0.080 |
Why?
|
| Parkinson Disease | 3 | 2020 | 2775 | 0.080 |
Why?
|
| Substantia Nigra | 1 | 2010 | 353 | 0.080 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2011 | 473 | 0.080 |
Why?
|
| Propaganda | 1 | 2008 | 5 | 0.080 |
Why?
|
| Genes | 1 | 1993 | 1893 | 0.080 |
Why?
|
| Lung Diseases | 1 | 1999 | 1886 | 0.080 |
Why?
|
| Cause of Death | 2 | 2010 | 3584 | 0.080 |
Why?
|
| Lithium Carbonate | 1 | 2009 | 184 | 0.080 |
Why?
|
| Monoamine Oxidase | 1 | 2008 | 178 | 0.080 |
Why?
|
| Neuroglia | 1 | 2014 | 927 | 0.080 |
Why?
|
| Myosin Type V | 1 | 2008 | 34 | 0.080 |
Why?
|
| Accidents, Traffic | 3 | 2022 | 819 | 0.080 |
Why?
|
| Excitatory Amino Acid Transporter 3 | 1 | 2007 | 32 | 0.080 |
Why?
|
| Cytoskeletal Proteins | 2 | 2017 | 1364 | 0.080 |
Why?
|
| Neurodegenerative Diseases | 2 | 2014 | 1061 | 0.080 |
Why?
|
| Multiple Sclerosis | 1 | 2023 | 3079 | 0.080 |
Why?
|
| Arousal | 2 | 2008 | 1165 | 0.080 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2022 | 2208 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 10 | 3 | 2017 | 287 | 0.080 |
Why?
|
| Severity of Illness Index | 9 | 2019 | 15540 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 8 | 2 | 2010 | 460 | 0.080 |
Why?
|
| Europe | 3 | 2020 | 3339 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2008 | 323 | 0.080 |
Why?
|
| Opioid-Related Disorders | 1 | 2022 | 2065 | 0.080 |
Why?
|
| Parietal Lobe | 1 | 2012 | 838 | 0.080 |
Why?
|
| Patient Compliance | 1 | 1998 | 2684 | 0.080 |
Why?
|
| Mass Screening | 2 | 2022 | 5255 | 0.070 |
Why?
|
| Sexual Dysfunctions, Psychological | 1 | 2009 | 187 | 0.070 |
Why?
|
| Genes, Immediate-Early | 1 | 2007 | 101 | 0.070 |
Why?
|
| Frail Elderly | 1 | 2012 | 693 | 0.070 |
Why?
|
| Major Histocompatibility Complex | 2 | 2021 | 936 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2014 | 9959 | 0.070 |
Why?
|
| Sepsis | 1 | 2021 | 2593 | 0.070 |
Why?
|
| Cardiology | 1 | 2018 | 1668 | 0.070 |
Why?
|
| Adoption | 2 | 2005 | 97 | 0.070 |
Why?
|
| Electroencephalography | 4 | 2017 | 6150 | 0.070 |
Why?
|
| Siblings | 3 | 2008 | 854 | 0.070 |
Why?
|
| Genetics, Population | 2 | 2019 | 934 | 0.070 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 3047 | 0.070 |
Why?
|
| Retrospective Studies | 9 | 2023 | 77449 | 0.070 |
Why?
|
| Computational Biology | 2 | 2019 | 3521 | 0.070 |
Why?
|
| Benzodiazepines | 2 | 2010 | 1101 | 0.070 |
Why?
|
| Brazil | 2 | 2021 | 1270 | 0.070 |
Why?
|
| Mental Processes | 1 | 2008 | 249 | 0.070 |
Why?
|
| Jejunoileal Bypass | 1 | 1986 | 12 | 0.070 |
Why?
|
| Electrocardiography | 2 | 2013 | 6442 | 0.070 |
Why?
|
| Membrane Glycoproteins | 3 | 2008 | 3768 | 0.070 |
Why?
|
| Rodentia | 1 | 2008 | 261 | 0.070 |
Why?
|
| Membrane Proteins | 3 | 2020 | 7880 | 0.070 |
Why?
|
| Myosin Heavy Chains | 1 | 2008 | 414 | 0.070 |
Why?
|
| Stress Disorders, Traumatic, Acute | 1 | 2005 | 28 | 0.070 |
Why?
|
| Population Surveillance | 1 | 2017 | 2616 | 0.070 |
Why?
|
| Vitamin D | 1 | 2020 | 3223 | 0.070 |
Why?
|
| Social Behavior | 1 | 2012 | 1127 | 0.070 |
Why?
|
| Gene Expression Regulation | 4 | 2020 | 12072 | 0.070 |
Why?
|
| Amyloid beta-Peptides | 2 | 2016 | 3587 | 0.070 |
Why?
|
| Memory | 1 | 2015 | 2174 | 0.070 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2006 | 106 | 0.070 |
Why?
|
| Chromosome Breakage | 1 | 2006 | 173 | 0.070 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2009 | 360 | 0.070 |
Why?
|
| Protein Precursors | 2 | 2018 | 1154 | 0.070 |
Why?
|
| Diabetes Mellitus | 2 | 2022 | 5751 | 0.070 |
Why?
|
| Protons | 1 | 2011 | 1127 | 0.070 |
Why?
|
| RNA | 2 | 2013 | 2749 | 0.070 |
Why?
|
| Statistics, Nonparametric | 5 | 2017 | 2886 | 0.070 |
Why?
|
| Regression Analysis | 4 | 2014 | 6459 | 0.070 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2015 | 2408 | 0.070 |
Why?
|
| Genetic Heterogeneity | 3 | 2018 | 733 | 0.060 |
Why?
|
| Canada | 1 | 2010 | 2065 | 0.060 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2012 | 1203 | 0.060 |
Why?
|
| Ambulatory Care | 2 | 2011 | 2708 | 0.060 |
Why?
|
| Cocaine-Related Disorders | 1 | 2008 | 460 | 0.060 |
Why?
|
| Low Back Pain | 1 | 2013 | 956 | 0.060 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2006 | 257 | 0.060 |
Why?
|
| Mixed Function Oxygenases | 1 | 2006 | 272 | 0.060 |
Why?
|
| Inflammation | 2 | 2023 | 10638 | 0.060 |
Why?
|
| Social Isolation | 1 | 2007 | 365 | 0.060 |
Why?
|
| Proteoglycans | 2 | 2022 | 835 | 0.060 |
Why?
|
| Psychological Tests | 1 | 1987 | 651 | 0.060 |
Why?
|
| Parenting | 1 | 2010 | 679 | 0.060 |
Why?
|
| Age Factors | 4 | 2019 | 18370 | 0.060 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2019 | 2425 | 0.060 |
Why?
|
| Anti-Anxiety Agents | 2 | 1998 | 390 | 0.060 |
Why?
|
| Repressor Proteins | 3 | 2020 | 3023 | 0.060 |
Why?
|
| Weight Gain | 1 | 2014 | 2292 | 0.060 |
Why?
|
| Statistics as Topic | 3 | 2016 | 2373 | 0.060 |
Why?
|
| Mice | 7 | 2023 | 81183 | 0.060 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2019 | 3712 | 0.060 |
Why?
|
| Hypertension | 2 | 2021 | 8480 | 0.060 |
Why?
|
| Cues | 3 | 2013 | 873 | 0.060 |
Why?
|
| Lod Score | 2 | 2001 | 614 | 0.060 |
Why?
|
| Activities of Daily Living | 2 | 2017 | 2418 | 0.060 |
Why?
|
| Hybridization, Genetic | 2 | 1993 | 109 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 7279 | 0.050 |
Why?
|
| Neuropeptides | 1 | 2008 | 942 | 0.050 |
Why?
|
| Fathers | 1 | 2005 | 358 | 0.050 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2013 | 2268 | 0.050 |
Why?
|
| Nuclear Family | 2 | 2001 | 318 | 0.050 |
Why?
|
| Brain Ischemia | 1 | 2017 | 3265 | 0.050 |
Why?
|
| Models, Theoretical | 2 | 2013 | 3589 | 0.050 |
Why?
|
| Atrophy | 2 | 2018 | 1583 | 0.050 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 2282 | 0.050 |
Why?
|
| Glutamate Carboxypeptidase II | 2 | 2013 | 77 | 0.050 |
Why?
|
| Duty to Recontact | 1 | 2021 | 20 | 0.050 |
Why?
|
| Attention | 3 | 2010 | 2400 | 0.050 |
Why?
|
| Sampling Studies | 1 | 2003 | 623 | 0.050 |
Why?
|
| Time Factors | 4 | 2020 | 40075 | 0.050 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2022 | 51 | 0.050 |
Why?
|
| Drug Industry | 1 | 2008 | 746 | 0.050 |
Why?
|
| Software | 2 | 2015 | 4443 | 0.050 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2012 | 2305 | 0.050 |
Why?
|
| Reference Values | 4 | 2011 | 4982 | 0.050 |
Why?
|
| Poverty | 1 | 2013 | 2660 | 0.050 |
Why?
|
| Acute-Phase Proteins | 1 | 2023 | 262 | 0.050 |
Why?
|
| Mannose | 1 | 2022 | 124 | 0.050 |
Why?
|
| Sulfurtransferases | 1 | 2021 | 17 | 0.050 |
Why?
|
| Attitude to Health | 1 | 1991 | 2052 | 0.050 |
Why?
|
| Stomach | 1 | 1986 | 697 | 0.050 |
Why?
|
| Sleep | 1 | 2017 | 4623 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2017 | 8554 | 0.050 |
Why?
|
| Membrane Transport Proteins | 2 | 2005 | 1028 | 0.050 |
Why?
|
| Acetylglucosamine | 1 | 2023 | 191 | 0.050 |
Why?
|
| Trace Elements | 1 | 2023 | 198 | 0.050 |
Why?
|
| Molecular Chaperones | 1 | 2005 | 742 | 0.050 |
Why?
|
| Receptors, Purinergic P1 | 1 | 2001 | 109 | 0.050 |
Why?
|
| Enkephalins | 1 | 2001 | 154 | 0.050 |
Why?
|
| Cluster Analysis | 2 | 2022 | 2715 | 0.050 |
Why?
|
| Ferrochelatase | 1 | 2020 | 46 | 0.050 |
Why?
|
| Leukopoiesis | 1 | 2020 | 56 | 0.050 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2001 | 124 | 0.050 |
Why?
|
| Decision Support Techniques | 2 | 2008 | 1956 | 0.050 |
Why?
|
| Receptors, Kainic Acid | 1 | 2020 | 88 | 0.050 |
Why?
|
| Personality Development | 1 | 2001 | 245 | 0.050 |
Why?
|
| Serotonin | 1 | 2005 | 1017 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 4751 | 0.050 |
Why?
|
| Cross-Over Studies | 2 | 2013 | 2029 | 0.040 |
Why?
|
| Infant Behavior | 1 | 2001 | 156 | 0.040 |
Why?
|
| Telomere | 1 | 2006 | 910 | 0.040 |
Why?
|
| Neural Pathways | 3 | 2018 | 2972 | 0.040 |
Why?
|
| Antigens, Neoplasm | 1 | 2008 | 1988 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2017 | 8949 | 0.040 |
Why?
|
| Apolipoproteins E | 2 | 2018 | 1438 | 0.040 |
Why?
|
| Digestive System Diseases | 1 | 2021 | 147 | 0.040 |
Why?
|
| Education, Medical, Continuing | 1 | 2005 | 840 | 0.040 |
Why?
|
| Tics | 1 | 2000 | 70 | 0.040 |
Why?
|
| Proteins | 1 | 2014 | 6103 | 0.040 |
Why?
|
| Transferrin | 1 | 2020 | 295 | 0.040 |
Why?
|
| Pain Measurement | 3 | 2014 | 3420 | 0.040 |
Why?
|
| Recurrence | 2 | 2014 | 8340 | 0.040 |
Why?
|
| Mortality | 1 | 2010 | 2864 | 0.040 |
Why?
|
| Jurisprudence | 1 | 1999 | 110 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 15 | 2 | 2012 | 373 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2008 | 4186 | 0.040 |
Why?
|
| Crime | 1 | 2020 | 215 | 0.040 |
Why?
|
| Germany | 2 | 2011 | 862 | 0.040 |
Why?
|
| Double-Blind Method | 4 | 2017 | 12026 | 0.040 |
Why?
|
| Vital Capacity | 1 | 2021 | 925 | 0.040 |
Why?
|
| Education, Medical | 1 | 1991 | 1721 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2011 | 4554 | 0.040 |
Why?
|
| Privacy | 1 | 2021 | 239 | 0.040 |
Why?
|
| Agoraphobia | 1 | 1998 | 179 | 0.040 |
Why?
|
| Communication | 2 | 2024 | 3749 | 0.040 |
Why?
|
| Mosaicism | 1 | 2021 | 441 | 0.040 |
Why?
|
| Demography | 2 | 2015 | 1656 | 0.040 |
Why?
|
| Whole Body Imaging | 1 | 2020 | 280 | 0.040 |
Why?
|
| Urogenital Abnormalities | 1 | 2021 | 261 | 0.040 |
Why?
|
| Noise | 1 | 2020 | 279 | 0.040 |
Why?
|
| Hospitalization | 1 | 2018 | 10262 | 0.040 |
Why?
|
| Psychology, Clinical | 1 | 1998 | 42 | 0.040 |
Why?
|
| Survival Analysis | 2 | 2009 | 10252 | 0.040 |
Why?
|
| Physician's Role | 1 | 2005 | 943 | 0.040 |
Why?
|
| Marriage | 2 | 1992 | 339 | 0.040 |
Why?
|
| Anisotropy | 2 | 2012 | 1265 | 0.040 |
Why?
|
| Hormone Replacement Therapy | 1 | 2003 | 745 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2021 | 1588 | 0.040 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2021 | 664 | 0.040 |
Why?
|
| Gene Duplication | 1 | 2018 | 329 | 0.040 |
Why?
|
| Epidemiologic Studies | 1 | 2001 | 676 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2022 | 849 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2011 | 4286 | 0.040 |
Why?
|
| Disease Progression | 2 | 2011 | 13284 | 0.040 |
Why?
|
| Cooperative Behavior | 2 | 2015 | 1504 | 0.040 |
Why?
|
| Health Status | 2 | 2007 | 4034 | 0.040 |
Why?
|
| Hot Temperature | 2 | 2013 | 1354 | 0.040 |
Why?
|
| Luteal Phase | 1 | 1997 | 147 | 0.040 |
Why?
|
| Acid Anhydride Hydrolases | 1 | 2016 | 72 | 0.040 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 2017 | 91 | 0.040 |
Why?
|
| Folic Acid Deficiency | 1 | 2017 | 115 | 0.040 |
Why?
|
| Aminopeptidases | 1 | 2017 | 88 | 0.040 |
Why?
|
| Social Work | 1 | 1998 | 162 | 0.040 |
Why?
|
| Methionine Sulfoxide Reductases | 1 | 2017 | 76 | 0.040 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2022 | 895 | 0.040 |
Why?
|
| Oncogene Protein v-akt | 1 | 2016 | 135 | 0.040 |
Why?
|
| Ethanol | 1 | 2023 | 1342 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2020 | 1572 | 0.040 |
Why?
|
| Forced Expiratory Volume | 1 | 2021 | 1743 | 0.040 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor Receptors | 1 | 2016 | 13 | 0.040 |
Why?
|
| Wound Healing | 1 | 2007 | 2785 | 0.030 |
Why?
|
| Vasculitis | 1 | 2020 | 519 | 0.030 |
Why?
|
| Sorting Nexins | 1 | 2015 | 23 | 0.030 |
Why?
|
| Lipids | 2 | 2021 | 3305 | 0.030 |
Why?
|
| Food, Fortified | 1 | 2017 | 191 | 0.030 |
Why?
|
| Mammals | 1 | 2022 | 1143 | 0.030 |
Why?
|
| Homozygote | 2 | 2016 | 1785 | 0.030 |
Why?
|
| Muscle Tonus | 1 | 2015 | 81 | 0.030 |
Why?
|
| Cerebellum | 1 | 2023 | 1488 | 0.030 |
Why?
|
| Outpatients | 2 | 2019 | 1486 | 0.030 |
Why?
|
| Nutritional Requirements | 1 | 2017 | 286 | 0.030 |
Why?
|
| Data Collection | 1 | 2005 | 3341 | 0.030 |
Why?
|
| Pulmonary Ventilation | 1 | 1998 | 373 | 0.030 |
Why?
|
| Patient Dropouts | 1 | 1998 | 421 | 0.030 |
Why?
|
| Ethylene Glycols | 1 | 2016 | 156 | 0.030 |
Why?
|
| Rats | 4 | 2007 | 24260 | 0.030 |
Why?
|
| Health Care Costs | 1 | 2009 | 3209 | 0.030 |
Why?
|
| Information Storage and Retrieval | 1 | 2021 | 824 | 0.030 |
Why?
|
| Disclosure | 1 | 2021 | 736 | 0.030 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2017 | 249 | 0.030 |
Why?
|
| Cyclohexanols | 1 | 1996 | 127 | 0.030 |
Why?
|
| Decision Making | 1 | 2009 | 3887 | 0.030 |
Why?
|
| Cytokines | 1 | 2010 | 7322 | 0.030 |
Why?
|
| Systems Biology | 1 | 2019 | 469 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2016 | 2938 | 0.030 |
Why?
|
| Heart Rate | 1 | 2006 | 4091 | 0.030 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2019 | 491 | 0.030 |
Why?
|
| Vasomotor System | 1 | 2015 | 209 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2008 | 18029 | 0.030 |
Why?
|
| International Cooperation | 2 | 2013 | 1420 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2016 | 367 | 0.030 |
Why?
|
| Informed Consent | 1 | 2021 | 995 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2023 | 2187 | 0.030 |
Why?
|
| Photic Stimulation | 2 | 2012 | 2025 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2016 | 403 | 0.030 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2018 | 703 | 0.030 |
Why?
|
| Gene Expression | 1 | 2007 | 7799 | 0.030 |
Why?
|
| Chile | 1 | 2015 | 237 | 0.030 |
Why?
|
| Nortriptyline | 1 | 2014 | 81 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 2020 | 1602 | 0.030 |
Why?
|
| Massachusetts | 2 | 2018 | 8663 | 0.030 |
Why?
|
| Personality Tests | 1 | 2014 | 83 | 0.030 |
Why?
|
| Amitriptyline | 1 | 2014 | 110 | 0.030 |
Why?
|
| Birth Injuries | 1 | 2015 | 148 | 0.030 |
Why?
|
| Circadian Rhythm | 2 | 2009 | 2624 | 0.030 |
Why?
|
| Ovary | 1 | 2018 | 981 | 0.030 |
Why?
|
| Body Weight | 3 | 2013 | 4669 | 0.030 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2018 | 871 | 0.030 |
Why?
|
| Putamen | 1 | 2015 | 291 | 0.030 |
Why?
|
| HLA Antigens | 1 | 2019 | 1381 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 1997 | 1590 | 0.030 |
Why?
|
| Caudate Nucleus | 1 | 2015 | 393 | 0.030 |
Why?
|
| Judgment | 1 | 2015 | 281 | 0.030 |
Why?
|
| England | 1 | 2014 | 522 | 0.030 |
Why?
|
| Acupuncture Points | 1 | 2013 | 101 | 0.030 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2014 | 496 | 0.030 |
Why?
|
| Wounds and Injuries | 1 | 2005 | 2400 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2020 | 2203 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2022 | 21827 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2001 | 1881 | 0.030 |
Why?
|
| Dexamethasone | 1 | 2020 | 1951 | 0.030 |
Why?
|
| Secondary Prevention | 2 | 2010 | 1530 | 0.030 |
Why?
|
| Placebos | 1 | 1997 | 1676 | 0.030 |
Why?
|
| Peptide Fragments | 2 | 2018 | 5097 | 0.030 |
Why?
|
| Michigan | 1 | 2013 | 350 | 0.030 |
Why?
|
| Professional-Patient Relations | 1 | 1998 | 737 | 0.030 |
Why?
|
| Models, Anatomic | 1 | 2016 | 691 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2020 | 3002 | 0.030 |
Why?
|
| Sensory Gating | 1 | 2012 | 47 | 0.030 |
Why?
|
| Sweden | 1 | 2015 | 1345 | 0.030 |
Why?
|
| Saccades | 1 | 2014 | 246 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2020 | 1613 | 0.030 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2018 | 1205 | 0.030 |
Why?
|
| Feasibility Studies | 2 | 2012 | 5078 | 0.030 |
Why?
|
| Epistasis, Genetic | 1 | 2015 | 365 | 0.030 |
Why?
|
| Carbonic Anhydrases | 1 | 1993 | 115 | 0.030 |
Why?
|
| Survivors | 1 | 2023 | 2291 | 0.030 |
Why?
|
| Anticipation, Psychological | 1 | 2012 | 87 | 0.030 |
Why?
|
| Reduced Folate Carrier Protein | 1 | 2011 | 8 | 0.030 |
Why?
|
| Fornix, Brain | 1 | 2012 | 70 | 0.030 |
Why?
|
| Ferredoxin-NADP Reductase | 1 | 2011 | 12 | 0.030 |
Why?
|
| Internship and Residency | 1 | 1992 | 5788 | 0.030 |
Why?
|
| Estonia | 1 | 2011 | 53 | 0.030 |
Why?
|
| 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 1 | 2011 | 30 | 0.030 |
Why?
|
| Models, Psychological | 1 | 1996 | 811 | 0.030 |
Why?
|
| Leukocytes | 1 | 2020 | 2043 | 0.030 |
Why?
|
| Classification | 1 | 2012 | 129 | 0.030 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1993 | 768 | 0.030 |
Why?
|
| Mothers | 1 | 2022 | 2165 | 0.030 |
Why?
|
| Forecasting | 1 | 2021 | 2951 | 0.030 |
Why?
|
| Social Perception | 1 | 2015 | 425 | 0.030 |
Why?
|
| Long-Term Care | 1 | 1995 | 607 | 0.030 |
Why?
|
| Interviews as Topic | 2 | 2008 | 2539 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 1708 | 0.020 |
Why?
|
| Caffeine | 1 | 2016 | 699 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2014 | 767 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2017 | 1086 | 0.020 |
Why?
|
| Aniline Compounds | 1 | 2016 | 986 | 0.020 |
Why?
|
| Income | 1 | 2020 | 1913 | 0.020 |
Why?
|
| Baltimore | 1 | 2011 | 231 | 0.020 |
Why?
|
| RNA Interference | 1 | 2020 | 2889 | 0.020 |
Why?
|
| Inpatients | 1 | 2023 | 2518 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2016 | 1184 | 0.020 |
Why?
|
| China | 1 | 2017 | 2248 | 0.020 |
Why?
|
| Internal Medicine | 1 | 1998 | 1009 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2013 | 977 | 0.020 |
Why?
|
| History, 17th Century | 1 | 1991 | 111 | 0.020 |
Why?
|
| Medial Forebrain Bundle | 1 | 2010 | 45 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2020 | 3505 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2014 | 23403 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2011 | 245 | 0.020 |
Why?
|
| Mother-Child Relations | 1 | 2014 | 481 | 0.020 |
Why?
|
| Public Health | 1 | 2023 | 2603 | 0.020 |
Why?
|
| History, 18th Century | 1 | 1991 | 214 | 0.020 |
Why?
|
| Forearm | 1 | 2012 | 409 | 0.020 |
Why?
|
| Finland | 1 | 2011 | 602 | 0.020 |
Why?
|
| Nuclear Proteins | 2 | 2017 | 5853 | 0.020 |
Why?
|
| Skull | 1 | 2015 | 813 | 0.020 |
Why?
|
| Magnetoencephalography | 1 | 2014 | 623 | 0.020 |
Why?
|
| Gait | 1 | 2015 | 793 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2023 | 3313 | 0.020 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2013 | 365 | 0.020 |
Why?
|
| Reaction Time | 1 | 2016 | 2097 | 0.020 |
Why?
|
| Italy | 1 | 2011 | 832 | 0.020 |
Why?
|
| Pain Threshold | 1 | 2013 | 584 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2011 | 437 | 0.020 |
Why?
|
| Hematologic Neoplasms | 1 | 2021 | 1832 | 0.020 |
Why?
|
| Waist Circumference | 1 | 2013 | 917 | 0.020 |
Why?
|
| Acetaminophen | 1 | 2013 | 545 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 1997 | 4933 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2011 | 535 | 0.020 |
Why?
|
| Memory Disorders | 1 | 2016 | 1184 | 0.020 |
Why?
|
| Minisatellite Repeats | 1 | 2009 | 165 | 0.020 |
Why?
|
| Rest | 1 | 2014 | 901 | 0.020 |
Why?
|
| Nutritional Status | 1 | 2017 | 1609 | 0.020 |
Why?
|
| Confidentiality | 1 | 2013 | 612 | 0.020 |
Why?
|
| Chi-Square Distribution | 2 | 2008 | 3508 | 0.020 |
Why?
|
| Delivery, Obstetric | 1 | 2015 | 906 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2003 | 13033 | 0.020 |
Why?
|
| Australia | 1 | 2011 | 1170 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2009 | 374 | 0.020 |
Why?
|
| Auditory Perceptual Disorders | 1 | 2008 | 36 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2021 | 3479 | 0.020 |
Why?
|
| Acoustic Stimulation | 1 | 2012 | 1216 | 0.020 |
Why?
|
| Sample Size | 1 | 2011 | 845 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2010 | 798 | 0.020 |
Why?
|
| Child Abuse, Sexual | 1 | 2010 | 383 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2012 | 1460 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2015 | 2170 | 0.020 |
Why?
|
| Hostility | 1 | 2008 | 189 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 1992 | 2274 | 0.020 |
Why?
|
| Central Nervous System Stimulants | 1 | 2016 | 1148 | 0.020 |
Why?
|
| Psychometrics | 1 | 2016 | 3002 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 5867 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2011 | 783 | 0.020 |
Why?
|
| Dominance, Cerebral | 1 | 2008 | 635 | 0.020 |
Why?
|
| Netherlands | 1 | 2011 | 2170 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1999 | 10943 | 0.020 |
Why?
|
| Body Height | 1 | 2013 | 1577 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2008 | 513 | 0.020 |
Why?
|
| Vagotomy | 1 | 1986 | 83 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 3674 | 0.020 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2012 | 957 | 0.020 |
Why?
|
| Bezoars | 1 | 1986 | 30 | 0.020 |
Why?
|
| Marketing | 1 | 2008 | 212 | 0.020 |
Why?
|
| Environmental Exposure | 1 | 2020 | 4234 | 0.020 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2006 | 295 | 0.020 |
Why?
|
| Matched-Pair Analysis | 1 | 2006 | 288 | 0.020 |
Why?
|
| Dopamine beta-Hydroxylase | 1 | 2005 | 75 | 0.020 |
Why?
|
| Food | 1 | 2010 | 771 | 0.020 |
Why?
|
| Aggression | 1 | 2010 | 753 | 0.020 |
Why?
|
| Immobilization | 1 | 1986 | 236 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2017 | 3297 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2008 | 940 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 6365 | 0.020 |
Why?
|
| Biometry | 1 | 2007 | 558 | 0.020 |
Why?
|
| Orthognathic Surgical Procedures | 1 | 1986 | 115 | 0.020 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2015 | 1414 | 0.020 |
Why?
|
| Models, Biological | 1 | 2021 | 9583 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2016 | 3703 | 0.010 |
Why?
|
| Medical History Taking | 1 | 2008 | 783 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1999 | 12959 | 0.010 |
Why?
|
| Premature Birth | 1 | 2015 | 1721 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 1995 | 8642 | 0.010 |
Why?
|
| Social Adjustment | 1 | 1986 | 631 | 0.010 |
Why?
|
| Menopause | 1 | 2011 | 1626 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 3617 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2013 | 3200 | 0.010 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2005 | 291 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 2009 | 1462 | 0.010 |
Why?
|
| Predictive Value of Tests | 2 | 2014 | 15076 | 0.010 |
Why?
|
| Conflict of Interest | 1 | 2008 | 544 | 0.010 |
Why?
|
| Behavior, Addictive | 1 | 2008 | 462 | 0.010 |
Why?
|
| Violence | 1 | 2009 | 909 | 0.010 |
Why?
|
| Checklist | 1 | 2010 | 833 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2013 | 6489 | 0.010 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2009 | 1683 | 0.010 |
Why?
|
| Ethics, Medical | 1 | 2008 | 792 | 0.010 |
Why?
|
| Internet | 1 | 2015 | 3064 | 0.010 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2005 | 475 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2017 | 3507 | 0.010 |
Why?
|
| Choice Behavior | 1 | 2008 | 803 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2007 | 2297 | 0.010 |
Why?
|
| Respiratory Function Tests | 1 | 2006 | 1616 | 0.010 |
Why?
|
| Clozapine | 1 | 2005 | 498 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2013 | 3462 | 0.010 |
Why?
|
| Markov Chains | 1 | 2005 | 969 | 0.010 |
Why?
|
| Memory, Short-Term | 1 | 2008 | 975 | 0.010 |
Why?
|
| Crime Victims | 1 | 2005 | 322 | 0.010 |
Why?
|
| Age Distribution | 1 | 2007 | 2902 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2013 | 4420 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2013 | 3778 | 0.010 |
Why?
|
| Body Image | 1 | 1986 | 610 | 0.010 |
Why?
|
| Base Sequence | 2 | 2007 | 12797 | 0.010 |
Why?
|
| Anxiety, Separation | 1 | 2001 | 86 | 0.010 |
Why?
|
| Mitochondria | 1 | 2014 | 3520 | 0.010 |
Why?
|
| Thiazoles | 1 | 2008 | 1483 | 0.010 |
Why?
|
| Exons | 1 | 2007 | 2437 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 1993 | 3279 | 0.010 |
Why?
|
| Crohn Disease | 1 | 2013 | 2303 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 6171 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2016 | 6234 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 2008 | 1901 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2012 | 8324 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2013 | 3864 | 0.010 |
Why?
|
| Life Expectancy | 1 | 2005 | 1184 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 6538 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 3920 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2013 | 6256 | 0.010 |
Why?
|
| Apoptosis | 1 | 2015 | 9727 | 0.010 |
Why?
|
| Insulin | 1 | 2013 | 6580 | 0.010 |
Why?
|
| Piperazines | 1 | 2008 | 2488 | 0.010 |
Why?
|
| Oxygen | 1 | 2008 | 4189 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2007 | 8301 | 0.010 |
Why?
|
| Sexual Behavior | 1 | 1986 | 2057 | 0.010 |
Why?
|
| Burns | 1 | 2007 | 1815 | 0.010 |
Why?
|
| Quality of Life | 2 | 2009 | 12804 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2008 | 3610 | 0.010 |
Why?
|
| Patient Selection | 1 | 2008 | 4215 | 0.010 |
Why?
|
| Rats, Inbred BN | 1 | 1995 | 235 | 0.010 |
Why?
|
| Causality | 1 | 2001 | 1275 | 0.010 |
Why?
|
| Heterozygote | 1 | 2001 | 2804 | 0.010 |
Why?
|
| Boston | 1 | 2007 | 9313 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 1986 | 3188 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2001 | 7913 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1995 | 18111 | 0.000 |
Why?
|